search
Back to results

Prevention of Post-Stroke Hand/Wrist Flexion Deformity

Primary Purpose

Hand Deformities

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
BION stimulation
Sponsored by
University of Southern California
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hand Deformities focused on measuring Neuromuscular stimulator, Flexor deformities of wrist and fingers

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Diagnosis of hemiplegic stroke 6 months to 20 years prior to enrollment in this study;
  2. Paresis of extensors in the forearm;
  3. Demonstrable restriction of hand or wrist mobility (i.e. significant stretch response, defined as a 2+ or greater on the Ashworth scale, can be elicited in the finger or wrist flexor muscles, and the patient's resting hand posture is flexed when the patient is standing with the upper arm pendant and the elbow flexed);
  4. Age 18 years or older;
  5. Stable pattern of pain-medication use for at least one month prior to enrollment;
  6. Medically stable;
  7. Able to travel to the testing center;
  8. Mentally capable to understand and carry out the procedures and communicate concerns; and
  9. Able and willing to participate and provide informed consent.
  10. Ability to bring the wrist into neutral posture and the MCP joints into 30 degrees of flexion

Exclusion Criteria:

  1. Pregnant, nursing, or planning to become pregnant within the study timeframe;
  2. Presence of electronic implants (e.g., cardiac pacemaker, cochlear implant, neurostimulator, etc.);
  3. Presence of metallic implants, such as artificial elbow implants or metal screws, in the immediate field of the magnetic coil (on the arm between the fingers and the shoulder).
  4. Use of electrical stimulation for treatment of relevant extensor muscles in the past month;
  5. Inability to recruit muscles through surface electrical stimulation because of excessive adipose tissue;
  6. Presence of other unrelated hand or wrist pathologies; participating in other treatments including active physical therapy or drug therapy that affect their hand or wrist.
  7. Severe hemineglect; and
  8. Cancer or other serious illness, including a disease other than stroke resulting in motor dysfunction.

Sites / Locations

  • Rancho Los Angeles National Rehabilitation Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Active Comparator

Arm Label

1

2

3

Arm Description

BION™ Experimental Group

Surface Stimulation Group

Control Group with conservative therapy (Range of motion exercises)

Outcomes

Primary Outcome Measures

passive Range of Motion, active Range of Motion, Rancho Arm Function Scale, Fugl Meyer Function Scale

Secondary Outcome Measures

Full Information

First Posted
February 25, 2008
Last Updated
June 1, 2015
Sponsor
University of Southern California
search

1. Study Identification

Unique Protocol Identification Number
NCT00628537
Brief Title
Prevention of Post-Stroke Hand/Wrist Flexion Deformity
Official Title
BION Implantable Microstimulator
Study Type
Interventional

2. Study Status

Record Verification Date
June 2015
Overall Recruitment Status
Completed
Study Start Date
April 2004 (undefined)
Primary Completion Date
December 2008 (Actual)
Study Completion Date
December 2008 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Southern California

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The study looks at a new treatment for wrist and finger contractures -- a condition where the affected hand is in a "closed" position, with the wrist and fingers stiff and difficult to move from that position. We want to study if stimulation of wrist and finger muscles using an implanted neuromuscular stimulator (BION) will be more or less effective than doing passive exercises of the affected hand to improve the range of movement at wrist and finger joints. Subjects of this study will be randomized into one of three groups: one doing passive movement therapy; one receiving surface stimulation (electrical stimulation with electrodes on the skin of the arm) and one doing BION® therapy. The passive movement group will do therapy for 12 weeks. Subjects in either stimulation group will receive stimulation for 6 weeks and then only passive therapy for 6 weeks.
Detailed Description
BION™ Experimental Group Following implantation, the patients receiving BIONs will have a 3 to 7 day healing period. During this period, subjects will not receive active therapy. At the end of this healing period, subjects will come to the testing center so that the examiner can program the exercise patterns. They will be instructed to increase the strength of their muscle contractions as tolerance permits. The goal for the BION™ patients is to achieve 30 minutes of stimulation twice daily, using a cycled stimulation at frequencies adequate to produce tetanic contraction, (typically 25-35 pps) that raises the joint through full range of motion against gravity (a range graded as 3/5) based on the available range of motion. The intensity, duration and frequency of the exercise program will be modified according to the progress of the participant, so that the strength of the contraction is increased over time. Surface Stimulation Group Patients will be instructed to stimulate twice daily for 30 minutes through surface electrodes placed according to instructions that the subject has been given. Stimulus parameters will be similar to those reported in earlier successful stimulation studies. The parameters should achieve a tetanic contraction that raises the joint through full range of motion against gravity (graded 3/5) based on the patient's available range of motion, and cycled, typically at 25-35 pps, using stimulus ramps as necessary so that contractions are smoothly graded and comfortable. Every effort will be made to ensure that the parameters needed in this group are chosen to produce a similar type of contraction to that obtained with BION™ stimulation. Control Group with conservative therapy (Range of motion exercises) The research participant is instructed in self-administered, standard range of motion stretching exercises. If the patient is unable to stretch the fingers into extension, a family member or a care-giver will be instructed to assist. They will be instructed to exercise the affected hand twice daily, repeating the exercise a minimum of 15 times in each session for 6 weeks. Control subjects will return to the clinic every two weeks for the first 6 weeks and every 3 weeks during the follow-up period. During these visits, passive range of motion testing will be administered.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hand Deformities
Keywords
Neuromuscular stimulator, Flexor deformities of wrist and fingers

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
BION™ Experimental Group
Arm Title
2
Arm Type
Active Comparator
Arm Description
Surface Stimulation Group
Arm Title
3
Arm Type
Active Comparator
Arm Description
Control Group with conservative therapy (Range of motion exercises)
Intervention Type
Device
Intervention Name(s)
BION stimulation
Intervention Description
BION™ Experimental Group The goal for the BION™ patients is to achieve 30 minutes of stimulation twice daily, using a cycled stimulation at frequencies adequate to produce tetanic contraction, (typically 25-35 pps) that raises the joint through full range of motion against gravity (a range graded as 3/5) based on the available range of motion. Surface Stimulation Group Patients will be instructed to stimulate twice daily for 30 minutes through surface electrodes placed according to instructions that the subject has been given. Every effort will be made to ensure that the parameters needed in this group are chosen to produce a similar type of contraction to that obtained with BION™ stimulation. Control Group with conservative therapy (Range of motion exercises) The research participant is instructed in self-administered, standard range of motion stretching exercises.
Primary Outcome Measure Information:
Title
passive Range of Motion, active Range of Motion, Rancho Arm Function Scale, Fugl Meyer Function Scale
Time Frame
baseline, 2 weeks, 4 weeks and 6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of hemiplegic stroke 6 months to 20 years prior to enrollment in this study; Paresis of extensors in the forearm; Demonstrable restriction of hand or wrist mobility (i.e. significant stretch response, defined as a 2+ or greater on the Ashworth scale, can be elicited in the finger or wrist flexor muscles, and the patient's resting hand posture is flexed when the patient is standing with the upper arm pendant and the elbow flexed); Age 18 years or older; Stable pattern of pain-medication use for at least one month prior to enrollment; Medically stable; Able to travel to the testing center; Mentally capable to understand and carry out the procedures and communicate concerns; and Able and willing to participate and provide informed consent. Ability to bring the wrist into neutral posture and the MCP joints into 30 degrees of flexion Exclusion Criteria: Pregnant, nursing, or planning to become pregnant within the study timeframe; Presence of electronic implants (e.g., cardiac pacemaker, cochlear implant, neurostimulator, etc.); Presence of metallic implants, such as artificial elbow implants or metal screws, in the immediate field of the magnetic coil (on the arm between the fingers and the shoulder). Use of electrical stimulation for treatment of relevant extensor muscles in the past month; Inability to recruit muscles through surface electrical stimulation because of excessive adipose tissue; Presence of other unrelated hand or wrist pathologies; participating in other treatments including active physical therapy or drug therapy that affect their hand or wrist. Severe hemineglect; and Cancer or other serious illness, including a disease other than stroke resulting in motor dysfunction.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lucinda Baker, M.D.
Organizational Affiliation
University of Southern California
Official's Role
Principal Investigator
Facility Information:
Facility Name
Rancho Los Angeles National Rehabilitation Center
City
Downey
State/Province
California
ZIP/Postal Code
90242
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
16711659
Citation
Loeb GE, Richmond FJ, Baker LL. The BION devices: injectable interfaces with peripheral nerves and muscles. Neurosurg Focus. 2006 May 15;20(5):E2. doi: 10.3171/foc.2006.20.5.3.
Results Reference
result

Learn more about this trial

Prevention of Post-Stroke Hand/Wrist Flexion Deformity

We'll reach out to this number within 24 hrs